临床眼科杂志2017，Vol.25Issue(6)：494-497,4.DOI:10.3969/j.issn.1006-8422.2017.06.005
康柏西普治疗视网膜静脉阻塞继发黄斑水肿的回顾性观察分析
A retrospective study on intravitreal injections of Conbercept for macular edema secondary to retinal vein occlusion
高健 1赵冰莹 1许亚静 1郑洁 1付安琪 1刘伦1
作者信息
- 1. 230022合肥,安徽医科大学第一附属医院眼科
- 折叠
摘要
Abstract
Objective To evaluate effectiveness and safety of intravitreal injections of Conbercept for macular edema secondary to retinal vein occlusion.Methods It is retrospective case study.The patients were confirmed by clinical examination of macular edema secondary to retinal vein occlusion.24 cases were enrolled in this study.All the patients were treated with 0.5 mg Conbercept in the first three months.The BCVA,fundus manifestations,OCT and complications were observed every month.Results During the 1,2,3,6 months after treatment,the mean BCVA were all improved with statistically significant difference (P =0.000).During the 1,2,3,6 months after treatment,the mean CRT were all decreased with statistically significant difference (P =0.000).The BCVA of the 6th nonth were related with the BCVA at baseline (r =0.808,P =0.000).The BCVA of the 6th month were not related with CRT at baseline (r =0.334,P =0.111) or the 6th month (r =0.295,P =0.162).Conclusions Conbercept is safe and effective to treat macular edema secondary to retinal vein occlusion.And the BCVA after treatment were related with the BCVA at baseline.关键词
视网膜静脉阻塞/黄斑水肿/康柏西普Key words
Retinal vein occlusion/Macular edema/Conbercept引用本文复制引用
高健,赵冰莹,许亚静,郑洁,付安琪,刘伦..康柏西普治疗视网膜静脉阻塞继发黄斑水肿的回顾性观察分析[J].临床眼科杂志,2017,25(6):494-497,4.
